MedPath

Dexamethasone and Etoricoxib for Pain Prevention Following Periodontal Surgery

Phase 2
Completed
Conditions
Pain Control
Registration Number
NCT00970112
Lead Sponsor
Universidade Estadual de Ponta Grossa
Brief Summary

The purpose of this study is to investigate whether preemptive medication with dexamethasone or etoricoxib provides better pain management and control than placebo following periodontal surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients presenting moderate or severe periodontitis after nonsurgical periodontal treatment with clinical signs of inflammation
Exclusion Criteria
  • Pregnant
  • Diabetes mellitus
  • Heart diseases
  • Allergic to components of the medications
  • Risk of endocarditis

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
painup to 3 days

hourly for the 8 first hours after surgery 3 times a day on the following 3 days

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UEPG

🇧🇷

Ponta Grossa, Paraná, Brazil

UEPG
🇧🇷Ponta Grossa, Paraná, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.